Dr. Kesava Ramgopal Adavikolanu

Dr. Kesava Ramgopal Adavikolanu

Associate Professor, RADIATION ONCOLOGY
Dr. Kesava Ramgopal Adavikolanu

Designation : Associate Professor

Qualification :

Sl. No. Degree Year of passing Subject College/University
1 MBBS 2008 Not Required ANDHRA MEDICAL COLLEGE, VISAKHAPATNAM
2 MD 2013 RADIOTHERAPY NIZAMS INSTITUTE OF MEDICAL SCIENCES, HYDERABAD.
3 ECMO 2014 Oncology European Society of Medical Oncology (ESMO) certification in Medical Oncology.

Email :kesav.rt@aiimsmangalagiri.edu.in

Research Profile

Researchgate

Area of Interest

    • Cancer Biology
    • SRS
    • SBRT
    • Brain tumors
    • Cancer prevention

Memberships

    • ESMO -European Society of Medical Oncology
    • AROI  – Association Of Radiation Oncologists India

Honors / Awards

Honors and awards:

  1. Gold Medal in Pharmacology, Andhra Medical College, 2005.
  2. Tatachari Medal in Pathology, Andhra Medical College, 2005.
  3. Silver Jubilee committee Prize and Endowment medal in Social and Preventive Medicine, Andhra

Medical College, 2006.

  1. R.Krishnareddy Memorial Medal from AndhrapradeshAkademi of Sciences,2007.
  2. Award from 10th ICRO PG Teaching program held at BHU, Varanasi,2011.
  3. Selected for two Abstract presentations at Annual Conference of ASTRO( American Society for Radiation Oncology), 2012.
  4. Selected for Abstract presentation at Annual Conference of ASTRO( American Society for Radiation Oncology), 2013.
  5. Selected for Abstract presentation at Annual Conference of ASTRO( American Society for Radiation Oncology), 2014.
  6. Selected for Abstract presentation at Annual Conference of ASCO ( American Society for Clinical Oncology),2012.
  7. Selected for ESMO Preceptorship program in Colorectal  Cancers,Singapore – 2015.
  8. Selected for ESMO Preceptorship program in Prostate Cancer, Singapore, 2017

Selected for ESMO Preceptorship program in Gastrointestinal tumors

Publications

  1. Kumar S, Ramgopal A K. Post mastectomy chestwall irradiation of left sided breast cancer with single energy electron beam vs three dimensional conformal radiotherapy with photons – analysis of dosimetric parameters. IOSR j dent med sci. 2016;15(09):58–60.
  2. KesavaRamGopal A, Subbarayudu S, Raghavendrarao KV, Manikumar S, Subbarao N, Jagannathraonaidu KV. A Comparison of Dosimetric Parameters of Volumetric Modulated Arc Therapy and Three-Dimensional Conformal Radiotherapy in Left-Sided Chestwall Radiation Therapy.IOSR j dent med sci. 2019;18(9):68-71.
  3. Nukasani S, A KR, S S, Vk R, K J V. A retrospective study evaluating effectiveness of concurrent and adjuvant temozolamide in newly diagnosed glioblastoma multiforme in Indian population. IOSR j dent med sci. 2017;16(06):11–2.
  4. Sivaramakrishna TV, KesavaRamgopal A. Dynamic and Segmental Methods of Intensity Modulated Radiotherapy Delivery in Head and Neck Cancer–Analysis of Volumetric and Dosimetric Parameters. IOSR Journal of Dental and Medical Sciences. 2016;15(5):66-9.
  5. KesavaRamGopal A, Subbarayudu S, Raghavendrarao KV, Manikumar S, Subbarao N, Jagannathraonaidu KV. A Comparison of dosimetric parameters of volumetric modulated arc therapy and three dimensional conformal radiotherapy in locally advanced Carcinoma Cervix.IOSR j dent med sci. 2019;18(10):11–20
  6. Kumar S, Ramgopal K. Dynamic and segmental methods of intensity modulated radiotherapy delivery in prostate cancer – analysis of volumetric and dosimetric parameters. IOSR j dent med sci. 2016;15(08):61–4.
  7. Tv S, KesavaRamgopal A. AmeloblasticCarcinom of Maxilla: A Rare Entity.IOSR j dent med sci. 2016;15(04):45–8
  8. KesavaRamgopal A, Monica I, Pavankumar L, Syedakram K, Deepajoseph M, Fayazahmed S, et al. Comparative study of response, toxicity, and quality of life in locally-advanced head-and-neck cancers with concurrent chemoradiation therapy with 3 weekly cisplatin versus weekly cisplatin regimen. Int J Radiat Oncol Biol Phys. 2013;87(2):S479.
  9. KesavaRamgopal A, E V, Pamidighantam S, Lachi P, Nanditha B, Vindhyavasini A, et al. Conventional 2 phase versus simultaneous integrated boost methods of intensity modulated radiation therapy in carcinoma of the prostate—analysis of volumetric and dosimetric parameters. Int J Radiat Oncol Biol Phys. 2012;84(3):S788.
  10. Nukasani S, A KR, S S, Vk R, K J V. Post mastectomy chestwall irradiation of right sided breast cancer with single energy electron beam Vs three dimensional conformal radiotherapy with photons – Analysis of dosimetric parameters. IOSR j dent med sci. 2017;16(06):40–1.
  11. Adavikolanu KR, Malik M, Lachi P, Kothwal S, Deepajoseph, Syed FA, et al. Comparitive study of quality of life in locally advanced head and neck cancers with concurrent chemoradiotherpy with three weekly cisplatin versus weekly cisplatin regimen. J Clin Oncol. 2013;31(15_suppl):e17028–e17028.
  12. Adavikolanu KR, Syed FA, Malik M, Naidu J, Pamidighantam S, Sunkavalli V. Clinical profile and outcomes in glioblastoma multiforme: Institutional experience. J Clin Oncol. 2012;30(15_suppl):e12501–e12501.
  13. Malik M, Adavikolanu KR, Jilla S, Andra VV, Lella Y, Naidu KVJR, et al. Sporadic rectal cancers in young adults: Experience from a tertiary cancer center in India. J Clin Oncol. 2013;31(15_suppl):e14694–e14694.
  14. Lachi P, Malik M, Adavikolanu KR, Kothwal S, Deepajoseph, Syed FA, et al. Quality of life in patients of carcinoma cervix treated with chemoradiotherapy: A prospective study. J Clin Oncol. 2013;31(15_suppl):e16545–e16545.